✦ LIBER ✦

220 Taxol, ifospamide and carboplatin for NSCLC: A phase II study

✍ Scribed by Zaniboni, A.; Meriggl, F.; Bozzola, G.; Rizzi, A.; Muttia, S.; Alghisi, A.; Gentile, A.; Marini, G.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Taxol and carboplatin in combination in

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 166 KB

Phase II study of docetaxel and carbopla

✍ Wachters, Floris M; van Putten, John W.G; Boezen, H.Marike; Groen, Harry J.M 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 112 KB

186 Polychemotherapy with carboplatin (C

✍ von Bültzingslöwen, F.; Stoppert, C.; Weiß, J.; Matthiessen, W.; Syriste, T.; Vi 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 292 KB

A phase I–II study with carboplatin (C)

✍ Fabi, A.; Barduagni, M.; De Marco, S.; De Marinis, F.; Cortesi, E.; Foggi, C.M.; 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 330 KB

Phase I/II study of weekly docetaxel (D)

✍ Griesinger, F; Leugering, J; Metz, M; Brittinger, G 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 103 KB

Phase II study of Topotecan (T) IV with

✍ Pujol, J.L; von Pawel, J; Tumolo, S; Martoni, A; Hearn, S; Fields, S.Z; Ross, G 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 140 KB